NOVO-B.CO CHMP opinion: Thursday, September 17, 2026
Variation type II · Ozempic · Update of section 5.1 of the SmPC in order to update the mechanism of action (MoA), based on final results from study NN9535-4662 (REMODEL); this is a 52- week, multi-centre, international, randomised, double-blinded, parallel-group, placebo-controlled trial to study th
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.